CPRI has a total area of more than 9,000 ㎡ laboratory for research and development purposes, equipped with state-of-the-art analysis devices and other 1000+ analysis and testing equipment for routine purposes, such as X-ray powder diffraction, HPLC and LC-MS. CPRI had established a Chiral Drug R&D platform; transdermal formulation platform, fast dissolving film and taste-masking technology platform, sustained release formulation platform, drug candidate screening platform, API pilot plant conforming cGMP and a to-be-build formulation technology engineering center.